EU project to launch five RFID pilot tests

Following a year of research and development, the EU-funded BRIDGE project is now preparing five pilots to test Electronic Product Code (EPC) and Radio Frequency Identification (RFID) technologies.

The pilots, scheduled to start in September, will test RFID across several sectors of industry including retail, pharmaceutical, manufacturing, distribution and logistics, and services.

The Electronic Product Code (EPC) is a family of coding schemes created to succeed the bar code. It was created as a low-cost method of tracking goods using RFID technology. RFID is a method of identifying unique items using radio waves. Typically, a reader communicates with a tag, which holds digital information in a microchip.

BRIDGE (Building Radio frequency IDentification solutions for the Global Environment) is a three-year €7.5 million project funded under the EU's Sixth Framework Programme (FP6). It is made up of a consortium of 30 partners from the worlds of industry and research.

BRIDGE was created to research, develop and implement tools enabling RFID and EPCglobal applications, as well as to drive the acceptance of EPCglobal standards in Europe.

The first pilot to go live will test the use of EPC second-generation technology to track pallets of pharmaceutical products as they move through the supply chain, from the manufacturers through distributor networks and on to hospitals and pharmacies.

"The purpose of the pilot is to use RFID to know where the goods come from, and where they are at any given moment," said Henri Barthel, the coordinator of the BRIDGE project. "With RFID, the idea is that the technology can help companies manage the supply chain in a much more accurate and efficient manner."

The pilot will aim to trace a number of products, identified at the carton and pallet levels using EPC RFID tags and 2-D bar-code labels. According to the organisers, deploying this 'hybrid environment' of RFID and bar-coding will afford them the chance to discover the pros and cons of each technology. In addition to RFID tags and 2-D bar-code labels, the pilot will incorporate a network-based system allowing the participants in the project to store, access and analyse all data collected during the experiment.

Ultimately, the objective of the pilot will be to increase the safety of patients by improving the traceability of pharmaceutical products and certifying the pedigree or authenticity of these as they move from the manufacturer to the final user.

Another pilot will be in the retail sector where BRIDGE will test the use of second generation EPC RFID to track cartons and pallets of clothing from the point of manufacture to the store. The pilot will track the goods as they move across the supply chain, but could also include novel in-store applications such as using RFID tags to identify individual garments, and installing RFID interrogators in dressing rooms so shoppers could obtain detailed product information about the items they are trying on, such as sizes, prices and availability.

Lastly, three more similar pilots will take place in food manufacturing processes, reusable assets and products in-service. The results of all five pilots will be made available by the project as it seeks to promote the uptake of standardised EPC and RFID technology for use in global supply chains.

"Since its inception, RFID has been hailed as the panacea for a more sophisticated and efficient global supply chain," said Mr Barthel. "The BRIDGE project will transform RFID from being an identification technology into providing an EPCglobal based product information network."

For further information, please visit:
http://www.bridge-project.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...